Ankit Tandon
Partner
DelhiPractice Area
Sectors
I am passionate about my work and strive to deliver high quality, simple and practical advice to all my clients, while taking on board suggestions offered by all parties.
Ankit Tandon has over 15 years of experience and specializes in Corporate / M&A, Private Equity and White–Collar Crime related matters. He regularly advises listed and unlisted entities across different sectors including food & beverages, pharmaceuticals, specialty chemicals, consultancy services, healthcare, information technology and gaming on fund raising, acquisition/disinvestments, business transfer arrangements, joint venture arrangements and general corporate related matters. His experience ranges from structuring investments, formulating entry and exit strategies for foreign investors and governance issues to advising on acquisitions, investments and exits in India and abroad, takeovers, foreign investment regulations, securities related laws, and complex regulatory issues. Additionally, Ankit also handles the Firm’s White-Collar Crime and Compliance & Investigation mandates and has conducted investigations on behalf of several clients (listed and unlisted) on accounting/financial impropriety, vendor onboarding, etc.
WORK HIGHLIGHTS
-
On its acquisition of 24.92% stake in 360 One WAM Limited (formerly known as IIFL Wealth Management Ltd), a first of a kind deal involving acquisition of control by a private equity firm of an asset management company registered with the Securities Exchange Board of India
-
On its investment in Swiggy (as a part of its US$ 700 million round) along with several other marquee investors at a US$ 10.7 billion valuation
-
On its (i) Disinvestment of ‘Horlicks’ and other Consumer Healthcare nutrition products in India to Unilever, including the merger of its Indian listed entity, GlaxoSmithKline Consumer Healthcare Limited with Hindustan Unilever Limited and subsequent sale of approximately 5.69% stake of HUL on the floor of the stock exchange, the largest secondary trade on Indian stock exchanges, awarded ‘Deal of the Year’ by IBLJ (2019) & (2020) respectively (ii) Separation of its pharmaceutical and consumer healthcare business, which involved setting up a joint venture arrangement with Pfizer Inc. for the consumer healthcare business ‘Haleon’
-
On its fund raise from Saudi Agricultural and Livestock Investment Company, a wholly owned subsidiary of the Public Investment Fund of the Kingdom of Saudi Arabia
-
On the sale of a majority stake to Lightock India for US$ 15 million
-
On its (i) Latest funding round of US$102 million led by Nepean Capital and some of its existing investors including Orios Venture Partners and Matrix Partners India, valuing the company at US$600 million (ii) Partnership with Reliance Jio Platforms, under which Zupee will distribute its content to users of Jio phones
-
On its acquisition of 24.92% stake in 360 One WAM Limited (formerly known as IIFL Wealth Management Ltd), a first of a kind deal involving acquisition of control by a private equity firm of an asset management company registered with the Securities Exchange Board of India
-
On its investment in Swiggy (as a part of its US$ 700 million round) along with several other marquee investors at a US$ 10.7 billion valuation
-
On its (i) Disinvestment of ‘Horlicks’ and other Consumer Healthcare nutrition products in India to Unilever, including the merger of its Indian listed entity, GlaxoSmithKline Consumer Healthcare Limited with Hindustan Unilever Limited and subsequent sale of approximately 5.69% stake of HUL on the floor of the stock exchange, the largest secondary trade on Indian stock exchanges, awarded ‘Deal of the Year’ by IBLJ (2019) & (2020) respectively (ii) Separation of its pharmaceutical and consumer healthcare business, which involved setting up a joint venture arrangement with Pfizer Inc. for the consumer healthcare business ‘Haleon’
-
On its fund raise from Saudi Agricultural and Livestock Investment Company, a wholly owned subsidiary of the Public Investment Fund of the Kingdom of Saudi Arabia
-
On the sale of a majority stake to Lightock India for US$ 15 million
-
On its (i) Latest funding round of US$102 million led by Nepean Capital and some of its existing investors including Orios Venture Partners and Matrix Partners India, valuing the company at US$600 million (ii) Partnership with Reliance Jio Platforms, under which Zupee will distribute its content to users of Jio phones
-
On its acquisition of 24.92% stake in 360 One WAM Limited (formerly known as IIFL Wealth Management Ltd), a first of a kind deal involving acquisition of control by a private equity firm of an asset management company registered with the Securities Exchange Board of India
-
On its investment in Swiggy (as a part of its US$ 700 million round) along with several other marquee investors at a US$ 10.7 billion valuation
-
On its (i) Disinvestment of ‘Horlicks’ and other Consumer Healthcare nutrition products in India to Unilever, including the merger of its Indian listed entity, GlaxoSmithKline Consumer Healthcare Limited with Hindustan Unilever Limited and subsequent sale of approximately 5.69% stake of HUL on the floor of the stock exchange, the largest secondary trade on Indian stock exchanges, awarded ‘Deal of the Year’ by IBLJ (2019) & (2020) respectively (ii) Separation of its pharmaceutical and consumer healthcare business, which involved setting up a joint venture arrangement with Pfizer Inc. for the consumer healthcare business ‘Haleon’
-
On its fund raise from Saudi Agricultural and Livestock Investment Company, a wholly owned subsidiary of the Public Investment Fund of the Kingdom of Saudi Arabia
-
On the sale of a majority stake to Lightock India for US$ 15 million
-
On its (i) Latest funding round of US$102 million led by Nepean Capital and some of its existing investors including Orios Venture Partners and Matrix Partners India, valuing the company at US$600 million (ii) Partnership with Reliance Jio Platforms, under which Zupee will distribute its content to users of Jio phones
-
On its acquisition of 24.92% stake in 360 One WAM Limited (formerly known as IIFL Wealth Management Ltd), a first of a kind deal involving acquisition of control by a private equity firm of an asset management company registered with the Securities Exchange Board of India
-
On its investment in Swiggy (as a part of its US$ 700 million round) along with several other marquee investors at a US$ 10.7 billion valuation
-
On its (i) Disinvestment of ‘Horlicks’ and other Consumer Healthcare nutrition products in India to Unilever, including the merger of its Indian listed entity, GlaxoSmithKline Consumer Healthcare Limited with Hindustan Unilever Limited and subsequent sale of approximately 5.69% stake of HUL on the floor of the stock exchange, the largest secondary trade on Indian stock exchanges, awarded ‘Deal of the Year’ by IBLJ (2019) & (2020) respectively (ii) Separation of its pharmaceutical and consumer healthcare business, which involved setting up a joint venture arrangement with Pfizer Inc. for the consumer healthcare business ‘Haleon’
-
On its fund raise from Saudi Agricultural and Livestock Investment Company, a wholly owned subsidiary of the Public Investment Fund of the Kingdom of Saudi Arabia
-
On the sale of a majority stake to Lightock India for US$ 15 million
-
On its (i) Latest funding round of US$102 million led by Nepean Capital and some of its existing investors including Orios Venture Partners and Matrix Partners India, valuing the company at US$600 million (ii) Partnership with Reliance Jio Platforms, under which Zupee will distribute its content to users of Jio phones
-
On its acquisition of 24.92% stake in 360 One WAM Limited (formerly known as IIFL Wealth Management Ltd), a first of a kind deal involving acquisition of control by a private equity firm of an asset management company registered with the Securities Exchange Board of India
-
On its investment in Swiggy (as a part of its US$ 700 million round) along with several other marquee investors at a US$ 10.7 billion valuation
-
On its (i) Disinvestment of ‘Horlicks’ and other Consumer Healthcare nutrition products in India to Unilever, including the merger of its Indian listed entity, GlaxoSmithKline Consumer Healthcare Limited with Hindustan Unilever Limited and subsequent sale of approximately 5.69% stake of HUL on the floor of the stock exchange, the largest secondary trade on Indian stock exchanges, awarded ‘Deal of the Year’ by IBLJ (2019) & (2020) respectively (ii) Separation of its pharmaceutical and consumer healthcare business, which involved setting up a joint venture arrangement with Pfizer Inc. for the consumer healthcare business ‘Haleon’
-
On its fund raise from Saudi Agricultural and Livestock Investment Company, a wholly owned subsidiary of the Public Investment Fund of the Kingdom of Saudi Arabia
-
On the sale of a majority stake to Lightock India for US$ 15 million
-
On its (i) Latest funding round of US$102 million led by Nepean Capital and some of its existing investors including Orios Venture Partners and Matrix Partners India, valuing the company at US$600 million (ii) Partnership with Reliance Jio Platforms, under which Zupee will distribute its content to users of Jio phones
-
On its acquisition of 24.92% stake in 360 One WAM Limited (formerly known as IIFL Wealth Management Ltd), a first of a kind deal involving acquisition of control by a private equity firm of an asset management company registered with the Securities Exchange Board of India
-
On its investment in Swiggy (as a part of its US$ 700 million round) along with several other marquee investors at a US$ 10.7 billion valuation
-
On its (i) Disinvestment of ‘Horlicks’ and other Consumer Healthcare nutrition products in India to Unilever, including the merger of its Indian listed entity, GlaxoSmithKline Consumer Healthcare Limited with Hindustan Unilever Limited and subsequent sale of approximately 5.69% stake of HUL on the floor of the stock exchange, the largest secondary trade on Indian stock exchanges, awarded ‘Deal of the Year’ by IBLJ (2019) & (2020) respectively (ii) Separation of its pharmaceutical and consumer healthcare business, which involved setting up a joint venture arrangement with Pfizer Inc. for the consumer healthcare business ‘Haleon’
-
On its fund raise from Saudi Agricultural and Livestock Investment Company, a wholly owned subsidiary of the Public Investment Fund of the Kingdom of Saudi Arabia
-
On the sale of a majority stake to Lightock India for US$ 15 million
-
On its (i) Latest funding round of US$102 million led by Nepean Capital and some of its existing investors including Orios Venture Partners and Matrix Partners India, valuing the company at US$600 million (ii) Partnership with Reliance Jio Platforms, under which Zupee will distribute its content to users of Jio phones
-
On its acquisition of 24.92% stake in 360 One WAM Limited (formerly known as IIFL Wealth Management Ltd), a first of a kind deal involving acquisition of control by a private equity firm of an asset management company registered with the Securities Exchange Board of India
-
On its investment in Swiggy (as a part of its US$ 700 million round) along with several other marquee investors at a US$ 10.7 billion valuation
-
On its (i) Disinvestment of ‘Horlicks’ and other Consumer Healthcare nutrition products in India to Unilever, including the merger of its Indian listed entity, GlaxoSmithKline Consumer Healthcare Limited with Hindustan Unilever Limited and subsequent sale of approximately 5.69% stake of HUL on the floor of the stock exchange, the largest secondary trade on Indian stock exchanges, awarded ‘Deal of the Year’ by IBLJ (2019) & (2020) respectively (ii) Separation of its pharmaceutical and consumer healthcare business, which involved setting up a joint venture arrangement with Pfizer Inc. for the consumer healthcare business ‘Haleon’
-
On its fund raise from Saudi Agricultural and Livestock Investment Company, a wholly owned subsidiary of the Public Investment Fund of the Kingdom of Saudi Arabia
-
On the sale of a majority stake to Lightock India for US$ 15 million
-
On its (i) Latest funding round of US$102 million led by Nepean Capital and some of its existing investors including Orios Venture Partners and Matrix Partners India, valuing the company at US$600 million (ii) Partnership with Reliance Jio Platforms, under which Zupee will distribute its content to users of Jio phones
-
On its acquisition of 24.92% stake in 360 One WAM Limited (formerly known as IIFL Wealth Management Ltd), a first of a kind deal involving acquisition of control by a private equity firm of an asset management company registered with the Securities Exchange Board of India
-
On its investment in Swiggy (as a part of its US$ 700 million round) along with several other marquee investors at a US$ 10.7 billion valuation
-
On its (i) Disinvestment of ‘Horlicks’ and other Consumer Healthcare nutrition products in India to Unilever, including the merger of its Indian listed entity, GlaxoSmithKline Consumer Healthcare Limited with Hindustan Unilever Limited and subsequent sale of approximately 5.69% stake of HUL on the floor of the stock exchange, the largest secondary trade on Indian stock exchanges, awarded ‘Deal of the Year’ by IBLJ (2019) & (2020) respectively (ii) Separation of its pharmaceutical and consumer healthcare business, which involved setting up a joint venture arrangement with Pfizer Inc. for the consumer healthcare business ‘Haleon’
-
On its fund raise from Saudi Agricultural and Livestock Investment Company, a wholly owned subsidiary of the Public Investment Fund of the Kingdom of Saudi Arabia
-
On the sale of a majority stake to Lightock India for US$ 15 million
-
On its (i) Latest funding round of US$102 million led by Nepean Capital and some of its existing investors including Orios Venture Partners and Matrix Partners India, valuing the company at US$600 million (ii) Partnership with Reliance Jio Platforms, under which Zupee will distribute its content to users of Jio phones
-
On its acquisition of 24.92% stake in 360 One WAM Limited (formerly known as IIFL Wealth Management Ltd), a first of a kind deal involving acquisition of control by a private equity firm of an asset management company registered with the Securities Exchange Board of India
-
On its investment in Swiggy (as a part of its US$ 700 million round) along with several other marquee investors at a US$ 10.7 billion valuation
-
On its (i) Disinvestment of ‘Horlicks’ and other Consumer Healthcare nutrition products in India to Unilever, including the merger of its Indian listed entity, GlaxoSmithKline Consumer Healthcare Limited with Hindustan Unilever Limited and subsequent sale of approximately 5.69% stake of HUL on the floor of the stock exchange, the largest secondary trade on Indian stock exchanges, awarded ‘Deal of the Year’ by IBLJ (2019) & (2020) respectively (ii) Separation of its pharmaceutical and consumer healthcare business, which involved setting up a joint venture arrangement with Pfizer Inc. for the consumer healthcare business ‘Haleon’
-
On its fund raise from Saudi Agricultural and Livestock Investment Company, a wholly owned subsidiary of the Public Investment Fund of the Kingdom of Saudi Arabia
-
On the sale of a majority stake to Lightock India for US$ 15 million
-
On its (i) Latest funding round of US$102 million led by Nepean Capital and some of its existing investors including Orios Venture Partners and Matrix Partners India, valuing the company at US$600 million (ii) Partnership with Reliance Jio Platforms, under which Zupee will distribute its content to users of Jio phones
-
On its acquisition of 24.92% stake in 360 One WAM Limited (formerly known as IIFL Wealth Management Ltd), a first of a kind deal involving acquisition of control by a private equity firm of an asset management company registered with the Securities Exchange Board of India
-
On its investment in Swiggy (as a part of its US$ 700 million round) along with several other marquee investors at a US$ 10.7 billion valuation
-
On its (i) Disinvestment of ‘Horlicks’ and other Consumer Healthcare nutrition products in India to Unilever, including the merger of its Indian listed entity, GlaxoSmithKline Consumer Healthcare Limited with Hindustan Unilever Limited and subsequent sale of approximately 5.69% stake of HUL on the floor of the stock exchange, the largest secondary trade on Indian stock exchanges, awarded ‘Deal of the Year’ by IBLJ (2019) & (2020) respectively (ii) Separation of its pharmaceutical and consumer healthcare business, which involved setting up a joint venture arrangement with Pfizer Inc. for the consumer healthcare business ‘Haleon’
-
On its fund raise from Saudi Agricultural and Livestock Investment Company, a wholly owned subsidiary of the Public Investment Fund of the Kingdom of Saudi Arabia
-
On the sale of a majority stake to Lightock India for US$ 15 million
-
On its (i) Latest funding round of US$102 million led by Nepean Capital and some of its existing investors including Orios Venture Partners and Matrix Partners India, valuing the company at US$600 million (ii) Partnership with Reliance Jio Platforms, under which Zupee will distribute its content to users of Jio phones
-
On its acquisition of 24.92% stake in 360 One WAM Limited (formerly known as IIFL Wealth Management Ltd), a first of a kind deal involving acquisition of control by a private equity firm of an asset management company registered with the Securities Exchange Board of India
-
On its investment in Swiggy (as a part of its US$ 700 million round) along with several other marquee investors at a US$ 10.7 billion valuation
-
On its (i) Disinvestment of ‘Horlicks’ and other Consumer Healthcare nutrition products in India to Unilever, including the merger of its Indian listed entity, GlaxoSmithKline Consumer Healthcare Limited with Hindustan Unilever Limited and subsequent sale of approximately 5.69% stake of HUL on the floor of the stock exchange, the largest secondary trade on Indian stock exchanges, awarded ‘Deal of the Year’ by IBLJ (2019) & (2020) respectively (ii) Separation of its pharmaceutical and consumer healthcare business, which involved setting up a joint venture arrangement with Pfizer Inc. for the consumer healthcare business ‘Haleon’
-
On its fund raise from Saudi Agricultural and Livestock Investment Company, a wholly owned subsidiary of the Public Investment Fund of the Kingdom of Saudi Arabia
-
On the sale of a majority stake to Lightock India for US$ 15 million
-
On its (i) Latest funding round of US$102 million led by Nepean Capital and some of its existing investors including Orios Venture Partners and Matrix Partners India, valuing the company at US$600 million (ii) Partnership with Reliance Jio Platforms, under which Zupee will distribute its content to users of Jio phones